Work

A Phase II Study of Combination Chemotherapy in Advanced Ovarian Carcinoma with Cisplatin and Cyclophosphamide plus Reduced Glutathione as Potential Protective Agent against Cisplatin Toxicity

FWCI: 0.639
Cites: 12
Cited by: 14
Related to: 10